Clinical Trial Update: A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety and efficacy of injectable risperidone to prevent mood episodes in bipolar disorder; results completed and posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• risperidone (injectable) (risperidone)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2009-02-27